Insurance cover

What NHIS pays for Magnesium Trisilicate + Aluminium Hydroxide

Magnesium Trisilicate + Aluminium Hydroxide (Magnesium Trisilicate + Aluminium Hydroxide Tablet Tablet) is on the National Health Insurance Scheme medicines list, edition March 2025. The scheme reimburses providers ₵0.22 per Magnesium Trisilicate + Aluminium Hydroxide Tablet Tablet. It may be prescribed from CHPS level upward (Community-based Health Planning and Services (the lowest level)). This is the scheme tariff, not a retail price.

Record

MATRALTA1

Generic

Magnesium Trisilicate + Aluminium Hydroxide

Presentation

Magnesium Trisilicate + Aluminium Hydroxide Tablet Tablet

NHIS tariff

₵0.22

Level of prescribing

A · CHPS

Scheme code

MATRALTA1

List edition

March 2025